Ascendiant
  • Home
  • About
    • About Us
    • Background
    • Our Name & Logo
  • Services
    • Corporate Finance
      • Overview
      • Transactions
      • Testimonials
      • Team
      • FAQs
    • Mergers & Acquisitions
      • Overview
      • Transactions
      • Testimonials
      • Team
      • FAQs
    • Equity Research
      • Overview
      • Research Coverage List
      • Research Reports
      • Team
    • Institutional Sales
      • Overview
      • Team
    • Market Making & Trading
      • Overview
      • FAQs
      • Team
  • Team
    • Investment Banking
      • Bradley J. Wilhite
      • R. Wayne Atwell, CFA
      • Kellee Bergendahl
      • Paul Fejtek
      • Christopher Gayde
      • Gary Gooderum
      • Scott B. Patten, CPA
      • William F. Peck
    • Equity Research
      • Edward M. Woo, CFA
      • Theodore R. O'Neill, IRC
    • Institutional Sales
      • Thomas A. (Tad) Dillon III, CFA
      • Chris Bedowitz
      • Ed Bradbury
      • Ed Bruksch
      • John Kurtz
      • Gregg Thatcher
    • Market Making & Trading
      • William M. (Billy) Johnson
      • Scott Levine
      • Adam Vaughan
      • Zachary Etrheim
      • Kevin Tufts
    • Compliance & Operations
      • Brian M. Megenity
      • Michael O. Brown
      • Jennifer Martin
      • Helen Bui
  • Resources
    • Transactions
    • M&A Transactions
    • Testimonials
    • News
    • Presentations
    • Research Coverage List
    • Research Reports
    • Secure Data Room
    • Legal Disclosures
  • Contact Us
  1. Services
  2. Equity Research
  3. Research Reports

Equity Research

  • Corporate Finance
  • Mergers & Acquisitions
  • Equity Research
    • Overview
    • Research Coverage List
    • Research Reports
    • Team
  • Institutional Sales
  • Market Making & Trading

Research Reports

To access Ascendiant's recent equity research initiations, please click on the link below.  For current reports, or for reports on companies not shown, please contact Edward Woo, Director of Research, at ewoo@ascendiant.com or 949.259.4932.

PAVmed Inc. (NasdaqGS: PAVM) - initiation

Atossa Therapeutics, Inc. (NasdaqCM: ATOS) - initiation

Phunware, Inc. (NasdaqGS: PHUN) - initiation

IMAC Holdings, Inc. (NasdaqGS: IMAC) - initiation

SINTX Technologies, Inc. (NasdaqCM: SINT) - initiation

Myomo, Inc. (NYSE American: MYO) - initiation

BioHiTech Global, Inc. (NasdaqCM: BHTG) - initiation

Nemaura Medical, Inc. (NasdaqCM: NMRD) - initiation

Daxor Corporation (NYSE American: DXR) - initiation

Monaker Group, Inc. (NasdaqCM: MKGI) - initiation

Outlook Therapeutics, Inc. (NasdaqCM: OTLK) - initiation

ENDRA Life Sciences, Inc. (NasdaqCM: NDRA) - initiation

FlexShopper, Inc. (NasdaqCM: FPAY) - initiation

Oragenics, Inc. (NYSE American: OGEN) - initiation

Hemispherx Biopharma, Inc. (NYSE American: HEB) - initiation 

Summit Wireless Technologies, Inc. (NasdaqCM: WISA) - initiation

ADOMANI, Inc. (NasdaqCM: ADOM) - initiation

MusclePharm Corporation (OTC: MSLP) - initiation

ENSERVCO Corporation (NYSE American: ENSV) - initiation

IsoRay, Inc. (NYSE American: ISR) - initiation

Aemetis, Inc. (NasdaqCM: AMTX) - initiation

ARCA biopharma, Inc. (NasdaqCM: ABIO) - initiation

Novus Therapeutics, Inc. (NasdaqCM: NVUS) - initiation

LRAD Corporation (NasdaqCM: LRAD) - initiation

Copyright © 2021 Ascendiant Capital Markets, LLC. Member FINRA & SIPC
Important Legal Information & Disclosures